Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Sci Rep ; 10(1): 20585, 2020 11 25.
Artigo em Inglês | MEDLINE | ID: mdl-33239684

RESUMO

Muscular dystrophies (MDs) are inherited disorders characterized by progressive muscle weakness. Previously, we have shown that resveratrol (3,5,4'-trihydroxy-trans-stilbene), an antioxidant and an activator of the protein deacetylase SIRT1, decreases muscular and cardiac oxidative damage and improves pathophysiological conditions in animal MD models. To determine whether resveratrol provides therapeutic benefits to patients with MDs, an open-label, single-arm, phase IIa trial of resveratrol was conducted in 11 patients with Duchenne, Becker or Fukuyama MD. The daily dose of resveratrol was 500 mg/day, which was increased every 8 weeks to 1000 and then 1500 mg/day. Primary outcomes were motor function, evaluated by a motor function measure (MFM) scale, muscular strength, monitored with quantitative muscle testing (QMT), and serum creatine kinase (CK) levels. Adverse effects and tolerability were evaluated as secondary outcomes. Despite the advanced medical conditions of the patients, the mean MFM scores increased significantly from 34.6 to 38.4 after 24 weeks of medication. A twofold increase was found in the mean QMT scores of scapula elevation and shoulder abduction. Mean CK levels decreased considerably by 34%. Diarrhoea and abdominal pain was noted in six and three patients, respectively. Resveratrol may provide some benefit to MD patients.


Assuntos
Atividade Motora/efeitos dos fármacos , Distrofias Musculares/tratamento farmacológico , Resveratrol/uso terapêutico , Adolescente , Adulto , Antioxidantes/uso terapêutico , Criança , Creatina Quinase/análise , Creatina Quinase/sangue , Feminino , Humanos , Japão , Masculino , Força Muscular/efeitos dos fármacos , Debilidade Muscular/tratamento farmacológico , Distrofias Musculares/fisiopatologia , Estilbenos/uso terapêutico , Adulto Jovem
2.
Kyobu Geka ; 63(9): 805-7, 2010 Aug.
Artigo em Japonês | MEDLINE | ID: mdl-20715463

RESUMO

Patient is 1 month old, 3.72 kg boy, he was diagnosed as {S, L, L} double-inlet left ventricle (DILV), transposition of the great arteries, coarctation of aorta, rudimentary right ventricle. Patient was undergone Norwood procedure, with "swing-back technique"; end-to end anastomosis of ascending aorta with descending aorta, double-barreled style Damus-Kaye-Stansel (DKS), end-to side anastomosis of neoaorta to aortic arch. This technique has following advantages over other reported technique; discrepancy of great arteries were resolved without distortion ; reconstruction of the aorta without the use of patch materials: minimal length suture line to minimize the risk of bleeding; and more radical excision of ductal tissue without much dissection and mobilization of descending aorta.


Assuntos
Coartação Aórtica/cirurgia , Ventrículos do Coração/anormalidades , Transposição dos Grandes Vasos/cirurgia , Procedimentos Cirúrgicos Cardíacos/métodos , Estenose Subaórtica Fixa/cirurgia , Humanos , Lactente , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...